Your selections:
- Hilliard, Fredrick A., Steele, Derek S., Laver, Derek, Yang, Zhaokang, Le Marchand, Sylvain J., Chopra, Nagesh, Piston, David W., Huke, Sabine, Knollmann, Björn C.
- Hwang, Hyun Seok, Hasdemir, Can, Laver, Derek, Mehra, Divya, Turhan, Kutsal, Faggioni, Michela, Yin, Huiyong, Knollmann, Björn C.
RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT
- Kryshtal, Dmytro O., Blackwell, Daniel J., Egly, Christian L., Smith, Abigail N., Batiste, Suzanne M., Johnston, Jeffrey N., Laver, Derek R., Knollmann, Bjorn C.
Multiple modes of ryanodine receptor 2 inhibition by flecainide
- Mehra, D., Imtiaz, M. S., van Helden, D. F., Knollmann, B. C., Laver, D. R.
Mechanisms of cardiac ryanodine receptor inhibition by anti arrhythmic drugs
Are you sure you would like to clear your session, including search history and login status?